Lexeo Therapeutics (LXEO) Stock: Buy, Sell, or Hold?
LXEO - Lexeo Therapeutics, Inc. Common Stock
$2.80
-0.09 (-3.11%)
âŧ
5d:
+6.06%
30d:
-17.4%
90d:
-37.36%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 04, 2026
10d
Get Alerted When LXEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LXEO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LXEO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LXEO is currently trading at $2.80, which is considered slightly low relative to its 30-day fair value range of $2.93 to $3.97.
Technical Outlook: Technically, LXEO is in a strong downtrend. Immediate support is located at $2.55, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.30 (+625.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LXEO is in a strong downtrend. Immediate support is located at $2.55, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.30 (+625.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.93 -
$3.97
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 625.0% below Wall St target ($20.30)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.93 -
$3.97
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.55
Resistance Level
$3.22
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.04
Wall Street Target
$20.30
(+625.0%)
Share & Embed Analysis
Last updated: October 24, 2026 2:02 AM ET
Data refreshes hourly during market hours. Next update: 3:02 AM
Data refreshes hourly during market hours. Next update: 3:02 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 64 BUY |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
20 analysts |
$650 | 65 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$864 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
